Total: 2281

    Hormonal contraceptive eligibility for women at high risk of HIV: guidance statement recommendations on contraceptive methods used by women at high risk of HIV

    The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime ...

    Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

    The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV. The first set of recommendation...

    Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups

    This guideline provides global, evidence-informed recommendations on preventive chemotherapy (deworming), as a public health intervention in areas endemic for soil-transmitted helminths, to decrease the worm burden of soil-transmitted helminth infections in children, adolescent girls, women of reproducti...

    WHO guidelines on protecting workers from potential risks of manufactured nanomaterials

    The term nanomaterials refers to materials that have at least one dimension (height, width or length) that is smaller than 100 nanometres (10−7 metre), which is about the size of a virus particle. This particular size dimension represents a major characteristic of manufactured nanomaterials (MNMs). The...